0.06EUR
1.14 MEUR
158.15 MEUR
14.34 M
About PHARMA MAR, S.A.
Sector
CEO
José Maria Fernández de Sousa-Faro
Headquarters
Colmenar Viejo
Website
Founded
1986
ISIN
ES0169501022
FIGI
BBG000F3LRQ5
Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.
Pharmamar PHMGood morning, today I present the analysis of PHM, a Spanish company pharmamar in the race for the vaccine against Covid19.
It is being a great trading year for this company.
The bullish structure marked by the yellow arrow has been broken, but the new structure, the bearish one, has not yet consoli
Pharmamar may reach 7,06€ +50%It seems that Pharmamar may reach 7,06€ (+50% from current price) after activating an iSHS and improving its rating.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PHM is 26.20 EUR — it has decreased by 1.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange PHARMA MAR, S.A. stocks are traded under the ticker PHM.
PHARMA MAR, S.A. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
PHM stock is 1.68% volatile and has beta coefficient of 0.73. Check out the list of the most volatile stocks — is PHARMA MAR, S.A. there?
One year price forecast for PHARMA MAR, S.A. has a max estimate of 70.00 EUR and a min estimate of 29.60 EUR.
PHM earnings for the last quarter are 0.08 EUR whereas the estimation was 0.22 EUR which accounts for −63.64% surprise. Estimated earnings for the next quarter are 0.08 EUR. See more details about PHARMA MAR, S.A. earnings.
PHARMA MAR, S.A. revenue for the last quarter amounts to 37.25 M EUR despite the estimated figure of 34.93 M EUR. In the next quarter revenue is expected to reach 41.80 M EUR.
Yes, you can track PHARMA MAR, S.A. financials in yearly and quarterly reports right on TradingView.
PHM stock has fallen by 5.69% compared to the previous week, the month change is a 7.75% fall, over the last year PHARMA MAR, S.A. has showed a 35.21% decrease.
PHM net income for the last quarter is −6.82 M EUR, while the quarter before that showed 1.52 M EUR of net income which accounts for −548.32% change. Track more PHARMA MAR, S.A. financial stats to get the full picture.
Today PHARMA MAR, S.A. has the market capitalization of 474.88 M, it has increased by 0.50% over the last week.
Yes, PHM dividends are paid annually. The last dividend per share was 0.53 EUR. As of today, Dividend Yield (TTM)% is 1.98%. Tracking PHARMA MAR, S.A. dividends might help you take more informed decisions.
Like other stocks, PHM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMA MAR, S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMA MAR, S.A. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMA MAR, S.A. stock shows the strong sell signal. See more of PHARMA MAR, S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PHARMA MAR, S.A. future price: according to them, PHM price has a max estimate of 70.00 EUR and a min estimate of 29.60 EUR. Read a more detailed PHARMA MAR, S.A. forecast: see what analysts think of PHARMA MAR, S.A. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMA MAR, S.A. EBITDA is 406.00 K EUR, and current EBITDA margin is 0.26%. See more stats in PHARMA MAR, S.A. financial statements.